Ocular hypotensive effect of brinzolamide after switching from dorzolamide

Japanese Journal of Clinical Ophthalmology

Volumn 58, Issue 3, 2004, Pages 301-303

  Kubota, Miyuki ^a   Hara, Takeshi ^a   Kubota, Shunsuke ^a   Hashimoto, Takako ^a   Tsuru, Tadahiko ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRINZOLAMIDE; DORZOLAMIDE; EYE DROPS;

ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FEMALE; HUMAN; INTRAOCULAR HYPOTENSION; INTRAOCULAR PRESSURE; MALE; OPEN ANGLE GLAUCOMA; OUTCOMES RESEARCH; PROSPECTIVE STUDY; TONOMETRY;

EID: 1842510685     PISSN: 03705579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (7)

1. Silver LH: Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhidrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group. Am J Opthalmol 126: 400-408, 1998
2. Lippa EA, Carlson LE, Ehinger B et al: Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol 110: 495-499, 1992